These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 39024549)

  • 1. Diverse Responses of Oligodendrocytes to Different FGF-Family Members: Uncoupling Structure-Function Relationship Within FGF Subfamilies.
    Guardiola-Diaz HM; DiBenedictis BT; Prendaj E; Bansal R
    ASN Neuro; 2024; 16(1):2371163. PubMed ID: 39024549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct fibroblast growth factor (FGF)/FGF receptor signaling pairs initiate diverse cellular responses in the oligodendrocyte lineage.
    Fortin D; Rom E; Sun H; Yayon A; Bansal R
    J Neurosci; 2005 Aug; 25(32):7470-9. PubMed ID: 16093398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Syndecan-3 and perlecan are differentially expressed by progenitors and mature oligodendrocytes and accumulate in the extracellular matrix.
    Winkler S; Stahl RC; Carey DJ; Bansal R
    J Neurosci Res; 2002 Aug; 69(4):477-87. PubMed ID: 12210841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific inhibitor of FGF receptor signaling: FGF-2-mediated effects on proliferation, differentiation, and MAPK activation are inhibited by PD173074 in oligodendrocyte-lineage cells.
    Bansal R; Magge S; Winkler S
    J Neurosci Res; 2003 Nov; 74(4):486-93. PubMed ID: 14598292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional evolutionary history of the mouse Fgf gene family.
    Itoh N; Ornitz DM
    Dev Dyn; 2008 Jan; 237(1):18-27. PubMed ID: 18058912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developmental stage-specific role of Frs adapters as mediators of FGF receptor signaling in the oligodendrocyte lineage cells.
    Furusho M; Ishii A; Hebert JM; Bansal R
    Glia; 2020 Mar; 68(3):617-630. PubMed ID: 31670856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of protein and lipid sulfation in oligodendrocytes blocks biological responses to FGF-2 and retards cytoarchitectural maturation, but not developmental lineage progression.
    Bansal R; Pfeiffer SE
    Dev Biol; 1994 Apr; 162(2):511-24. PubMed ID: 8150210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of FGF receptors in the oligodendrocyte lineage.
    Bansal R; Kumar M; Murray K; Morrison RS; Pfeiffer SE
    Mol Cell Neurosci; 1996 Apr; 7(4):263-75. PubMed ID: 8793862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibroblast growth factor enriches the embryonic liver cultures for hepatic progenitors.
    Sekhon SS; Tan X; Micsenyi A; Bowen WC; Monga SP
    Am J Pathol; 2004 Jun; 164(6):2229-40. PubMed ID: 15161655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin/Heparan sulfate domains in binding and signaling of fibroblast growth factor 8b.
    Loo BM; Salmivirta M
    J Biol Chem; 2002 Sep; 277(36):32616-23. PubMed ID: 12077148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FGF signaling controls Shh-dependent oligodendroglial fate specification in the ventral spinal cord.
    Farreny MA; Agius E; Bel-Vialar S; Escalas N; Khouri-Farah N; Soukkarieh C; Danesin C; Pituello F; Cochard P; Soula C
    Neural Dev; 2018 Mar; 13(1):3. PubMed ID: 29519242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro changes in plasma membrane heparan sulfate proteoglycans and in perlecan expression participate in the regulation of fibroblast growth factor 2 mitogenic activity.
    Guillonneau X; Tassin J; Berrou E; Bryckaert M; Courtois Y; Mascarelli F
    J Cell Physiol; 1996 Jan; 166(1):170-87. PubMed ID: 8557766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibroblast growth factor (FGF) homologous factors share structural but not functional homology with FGFs.
    Olsen SK; Garbi M; Zampieri N; Eliseenkova AV; Ornitz DM; Goldfarb M; Mohammadi M
    J Biol Chem; 2003 Sep; 278(36):34226-36. PubMed ID: 12815063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developmental and FGF-2-mediated regulation of syndecans (1-4) and glypican in oligodendrocytes.
    Bansal R; Kumar M; Murray K; Pfeiffer SE
    Mol Cell Neurosci; 1996 Apr; 7(4):276-88. PubMed ID: 8793863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of receptor and heparin binding sites in fibroblast growth factor 4 by structure-based mutagenesis.
    Bellosta P; Iwahori A; Plotnikov AN; Eliseenkova AV; Basilico C; Mohammadi M
    Mol Cell Biol; 2001 Sep; 21(17):5946-57. PubMed ID: 11486033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repression of myogenic differentiation by aFGF, bFGF, and K-FGF is dependent on cellular heparan sulfate.
    Olwin BB; Rapraeger A
    J Cell Biol; 1992 Aug; 118(3):631-9. PubMed ID: 1379245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diversification of the structural determinants of fibroblast growth factor-heparin interactions: implications for binding specificity.
    Xu R; Ori A; Rudd TR; Uniewicz KA; Ahmed YA; Guimond SE; Skidmore MA; Siligardi G; Yates EA; Fernig DG
    J Biol Chem; 2012 Nov; 287(47):40061-73. PubMed ID: 23019343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developmental expression of fibroblast growth factor (FGF) receptors in neural stem cell progeny. Modulation of neuronal and glial lineages by basic FGF treatment.
    Reimers D; López-Toledano MA; Mason I; Cuevas P; Redondo C; Herranz AS; Lobo MV; Bazán E
    Neurol Res; 2001 Sep; 23(6):612-21. PubMed ID: 11547930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression pattern of fibroblast growth factors (FGFs), their receptors and antagonists in primary endothelial cells and vascular smooth muscle cells.
    Antoine M; Wirz W; Tag CG; Mavituna M; Emans N; Korff T; Stoldt V; Gressner AM; Kiefer P
    Growth Factors; 2005 Jun; 23(2):87-95. PubMed ID: 16019430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A non-transformed oligodendrocyte precursor cell line, OL-1, facilitates studies of insulin-like growth factor-I signaling during oligodendrocyte development.
    Lagarde WH; Benjamin R; Heerens AT; Ye P; Cohen RI; Moats-Staats BM; D'Ercole AJ
    Int J Dev Neurosci; 2007 Apr; 25(2):95-105. PubMed ID: 17306496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.